Study shows benefits of newer-generation clot-busting drug
A team of neurologists at Dell Medical School at the University of Texas at Austin have been able to show that the new medicine tenecteplase outperforms the traditional alteplase treatment for ischemic strokes in several important areas, including better health outcomes and lower costs. The study has been published in the American Stroke Association´s journal Read More …